Management tracks

Gene editing company CRISPR Therapeutics AG (Basel, Switzerland) named Marc Becker CFO. He was CFO and SVP at rEVO Biologics Inc. (Framingham, Mass.). CRISPR also named Tony Coles, the chairman and CEO of Yumanity Therapeutics LLC (Cambridge, Mass.), as its chairman.

Antibody play Kymab Ltd. (Cambridge, U.K.) named David Chiswell CEO, effective next month. He had been interim CEO since Christian Grondahl stepped down in February 2015. Chiswell will resign as Kymab's chairman. ...